NCT05331066 Understanding immunE-related toXicities by multifACeT Profiling
| NCT ID | NCT05331066 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Royal Marsden NHS Foundation Trust |
| Condition | Oncology |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-04-06 |
| Primary Completion | 2028-04-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2022-04-06 with a primary completion date of 2028-04-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A prospective observational cohort study of patients undergoing CPI therapy in which translational research is the fundamental aspect of the study.
Eligibility Criteria
Inclusion Criteria: * Written informed consent * Age 18 years or older * Confirmed diagnosis of any form of solid malignancy with a clinical indication and appropriate treatment plan to commence immune checkpoint inhibitor therapy Exclusion Criteria: * Medical or psychological condition that would preclude informed consent * Planned participation in a drug trial receiving investigational agents * Subjects who have previously commenced immune checkpoint inhibitor therapy prior to study entry. * Subjects unable to comply with the study or sample schedule.
Contact & Investigator
Samra Turajlic
PRINCIPAL INVESTIGATOR
Royal Marsden NHS Foundation Trust
Frequently Asked Questions
Who can join the NCT05331066 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Oncology. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05331066 currently recruiting?
Yes, NCT05331066 is actively recruiting participants. Contact the research team at exact@rmh.nhs.uk for enrollment information.
Where is the NCT05331066 trial being conducted?
This trial is being conducted at Chelsea, United Kingdom.
Who is sponsoring the NCT05331066 clinical trial?
NCT05331066 is sponsored by Royal Marsden NHS Foundation Trust. The principal investigator is Samra Turajlic at Royal Marsden NHS Foundation Trust. The trial plans to enroll 200 participants.